ArticleDisease markers2018

Combination of Proteasome and Histone Deacetylase Inhibitors Overcomes the Impact of Gain-of-Function p53 Mutations.

Xiangbing Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.